Related Experiment Video
Updated: Aug 7, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases
Hila Toledano-Katchalski1, Judith Kraut, Tal Sines
1Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel.
Abstract:
Mitogen-activated protein kinases (MAPKs) mediate signaling from the cell membrane to the nucleus following their phosphorylation at conserved threonine and tyrosine residues within their activation loops. We show that protein tyrosine phosphatase epsilon (PTP epsilon) inhibits ERK1 and ERK2 kinase activity and reduces their phosphorylation; in agreement, ERK phosphorylation is increased in fibroblasts and in mammary tumor cells from mice genetically lacking PTP epsilon. PTP epsilon inhibits events downstream of ERKs, such as transcriptional activation mediated by Elk1 or by the serum response element. PTP epsilon also inhibits transcriptional activation mediated by c-Jun and C/EBP binding protein (CHOP) but not that mediated by the unrelated NFkB, attesting that it is broadly active within the MAPK family but otherwise specific. The effect of PTP epsilon on ERKs is at least in part indirect because phosphorylation of the threonine residue in the ERK activation loop is reduced in the presence of PTP epsilon. Nonetheless, PTP epsilon is present in a molecular complex with ERK, providing PTP epsilon with opportunity to act on ERK proteins also directly. We conclude that PTP epsilon is a physiological inhibitor of ERK signaling. Slow induction of PTP epsilon and its lack of nuclear translocation following mitogenic stimulation suggest that PTP epsilon functions to prevent inappropriate activation and to terminate prolonged, rather than acute, activation of ERK in the cytosol.
Insights
Protein tyrosine phosphatase epsilon (PTP epsilon) inhibits ERK1 and ERK2 signaling by reducing their phosphorylation. This phosphatase acts as a physiological regulator, preventing inappropriate and prolonged ERK activation.
Area of Science:
- Cellular signaling
- Molecular biology
- Signal transduction
Background:
- Mitogen-activated protein kinases (MAPKs) are crucial for cell signaling, transmitting signals from the cell membrane to the nucleus.
- MAPK activation involves phosphorylation at specific threonine and tyrosine residues within their activation loops.
Purpose of the Study:
- To investigate the role of protein tyrosine phosphatase epsilon (PTP epsilon) in regulating ERK1 and ERK2 activity.
- To determine the mechanism by which PTP epsilon affects MAPK signaling pathways.
Main Methods:
- Assessing PTP epsilon's effect on ERK1/ERK2 kinase activity and phosphorylation levels.
- Analyzing downstream transcriptional events mediated by ERKs, such as Elk1 and serum response element activation.
- Investigating PTP epsilon's presence in molecular complexes with ERK proteins.
Main Results:
- PTP epsilon inhibits ERK1 and ERK2 kinase activity and reduces their phosphorylation.
- ERK phosphorylation is elevated in cells lacking PTP epsilon.
- PTP epsilon suppresses downstream transcriptional activation mediated by Elk1, c-Jun, and CHOP, but not NFkB.
- PTP epsilon reduces threonine phosphorylation in the ERK activation loop and forms complexes with ERK.
Conclusions:
- PTP epsilon is a physiological inhibitor of ERK signaling.
- PTP epsilon prevents inappropriate and terminates prolonged ERK activation, primarily in the cytosol.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

